Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weishardt is a long-established French manufacturer of gelatin, marine collagen peptides, and texturizing solutions serving the food, nutraceutical, pharmaceutical, and beauty markets. Founded in 1839, the company is a global producer of pig skin, bovine hide, and fish-derived gelatin, and markets its marine collagen peptide range under the Naticol brand. In healthcare-related markets, Weishardt supplies pharmaceutical gelatin and collagen-based ingredients used in capsules, microencapsulation, supplements, and functional formulations rather than developing proprietary therapeutics. The company operates multiple production plants and exports a large majority of its sales internationally. Its business is best characterized as a commercial-stage specialty ingredients and excipients manufacturer with a strong position in marine collagen.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weishardt International.